Skip to main content
Premium Trial:

Request an Annual Quote

Novacyt Inks Supply Contract for Coronavirus Test With UK Health Agency

NEW YORK – Novacyt said Monday it has inked a supply contract with the UK Department of Health and Social Care (DHSC) for a COVID-19 PCR test developed by its Primerdesign molecular diagnostics division in the United Kingdom. 

Under the terms of the agreement, Novacyt will supply its test to the DHSC for an initial term of six months, starting May 4. Vélizy-Villacoublay, France-based Novacyt has initially committed to supply 288,000 tests per week to the DHSC for use in the NHS and has an option to expand the agreement. 

Financial and other terms of the agreement were not disclosed.

The partnership with the DHSC reinforces Novacyt's existing support of the UK government's five-pillar plan to increase testing for COVID-19, the firm said. Novacyt had announced in April that it is collaborating with AstraZeneca, GlaxoSmithKline, and the University of Cambridge to increase SARS-CoV-2 testing in the UK.

The Scan

Comfort of Home

The Guardian reports that AstraZeneca is to run more clinical trials from people's homes with the aim of increasing participant diversity.

Keep Under Control

Genetic technologies are among the tools suggested to manage invasive species and feral animals in Australia, Newsweek says.

Just Make It

The New York Times writes that there is increased interest in applying gene synthesis to even more applications.

Nucleic Acids Research Papers on OncoDB, mBodyMap, Genomicus

In Nucleic Acids Research this week: database to analyze large cancer datasets, human body microbe database, and more.